BACKGROUND: The recent literature suggests that the incidence and prevalence of myasthenia gravis (MG) are changing. We performed a population-based study of MG in the province of Trentino (524,826 inhabitants) and compared the results with those collected 20 years ago. METHODS: Multiple sources of information (discharge diagnosis, antibody tests and anticholinesterase drugs) were analyzed. Incidence was calculated from 2005 to 2009. Prevalence was calculated on December 31, 2009. Comparison was made with descriptive statistics for 1981-1990 for the identical region. RESULTS: Incidence and prevalence greatly increased in comparison with 1981-1990 data. The prevalence rate increased from 82.9 (95% confidence interval, CI, 58.4-114...
Background: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoan...
Department of Neurology, State University of Medicine and Pharmacy “Nicolae Testemiţanu”, Chişinău, ...
BACKGROUND: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoan...
The annual incidence of myasthenia gravis (MG) ranges from 3 to 30 per 1,000,000 people. Since the ...
This cooperative study was performed in the provinces of Bologna and Ferrara to estimate the prevale...
A multicentre retrospective study was carried out on the characteristics and course of myasthenia gr...
OBJECTIVES: To perform a comprehensive survey of myasthenia gravis in the county of Cambridgeshire...
BACKGROUND: The reported annual incidence of myasthenia gravis (MG) ranges from 0.25 to 15 per milli...
Introduction: The reported prevalence of myasthenia gravis ranges between 5 and 24 cases per 100,000...
Objectives—To perform a comprehensive survey of myasthenia gravis in the county of Cambridgeshire, E...
Myasthenia gravis is probably commoner than previously suspected, the annual incidence being nearer ...
NTRODUCTION: We planned a descriptive study on the incidence of intracranial gliomas spanning a 16-y...
Objectives: A number of worldwide studies have highlighted a rising incidence of myasthenia gravis (...
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: To provide an estimated ...
[Objective] To describe the characteristics of patients with very-late-onset myasthenia gravis (MG)....
Background: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoan...
Department of Neurology, State University of Medicine and Pharmacy “Nicolae Testemiţanu”, Chişinău, ...
BACKGROUND: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoan...
The annual incidence of myasthenia gravis (MG) ranges from 3 to 30 per 1,000,000 people. Since the ...
This cooperative study was performed in the provinces of Bologna and Ferrara to estimate the prevale...
A multicentre retrospective study was carried out on the characteristics and course of myasthenia gr...
OBJECTIVES: To perform a comprehensive survey of myasthenia gravis in the county of Cambridgeshire...
BACKGROUND: The reported annual incidence of myasthenia gravis (MG) ranges from 0.25 to 15 per milli...
Introduction: The reported prevalence of myasthenia gravis ranges between 5 and 24 cases per 100,000...
Objectives—To perform a comprehensive survey of myasthenia gravis in the county of Cambridgeshire, E...
Myasthenia gravis is probably commoner than previously suspected, the annual incidence being nearer ...
NTRODUCTION: We planned a descriptive study on the incidence of intracranial gliomas spanning a 16-y...
Objectives: A number of worldwide studies have highlighted a rising incidence of myasthenia gravis (...
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: To provide an estimated ...
[Objective] To describe the characteristics of patients with very-late-onset myasthenia gravis (MG)....
Background: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoan...
Department of Neurology, State University of Medicine and Pharmacy “Nicolae Testemiţanu”, Chişinău, ...
BACKGROUND: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoan...